Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

11/20/24 8:30:00 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $SDGR alert in real time by email

Schrödinger, Inc. (NASDAQ:SDGR) today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference. The live presentation will take place on Wednesday, December 4, 2024 at 8:30 a.m. ET.

The live webcast can be accessed in the "Investors" section of Schrödinger's website and will be archived for approximately 90 days following the event.

About Schrödinger

Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger's software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 900 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241120917578/en/

Get the next $SDGR alert in real time by email

Recent Analyst Ratings for

$SDGR

Date	Price Target	Rating	Analyst
7/2/2024	$29.00	Outperform	Leerink Partners
12/5/2023	$38.00	Overweight	KeyBanc Capital Markets
5/5/2023	$60.00	Overweight	Piper Sandler
12/19/2022	$23.00	Neutral	Goldman
3/1/2022	$55.00	Buy	Citigroup
11/19/2021	$82.00 → $49.00	Overweight → Equal-Weight	Morgan Stanley
11/19/2021	$87.00	Overweight	Piper Sandler
11/11/2021	$80.00 → $52.00	Buy → Neutral	B of A Securities

More analyst ratings

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

Chat with this insight

Recent Analyst Ratings for $SDGR

$SDGR Press Releases

Fastest customizable press release news feed in the world

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

$SDGR Financials

Live finance-specific insights

Schrödinger Reports Third Quarter 2024 Financial Results

Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12

$SDGR Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Medical Officer Dugan Margaret sold $27,226 worth of shares (1,531 units at $17.78), decreasing direct ownership by 10% to 13,469 units (SEC Form 4)

Director Chodakewitz Jeffrey was granted 5,000 shares, increasing direct ownership by 80% to 11,250 units (SEC Form 4)

Director Kapeller-Libermann Rosana was granted 5,000 shares, increasing direct ownership by 80% to 11,250 units (SEC Form 4)

$SDGR SEC Filings

SEC Form 10-Q filed by Schrodinger Inc.

Schrodinger Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

SEC Form S-8 filed by Schrodinger Inc.

$SDGR Large Ownership Changes

This live feed shows all institutional transactions in real time.

$SDGR Market Insights

Live Market Insights

SEC Form SC 13G filed by Schrodinger Inc.

SEC Form SC 13G/A filed by Schrodinger Inc. (Amendment)

SEC Form SC 13G/A filed by Schrodinger Inc. (Amendment)

What Analysts Are Saying About Schrodinger Stock

Keybanc Maintains Overweight on Schrodinger, Lowers Price Target to $25

Leerink Partners Initiates Coverage On Schrodinger with Outperform Rating, Announces Price Target of $29

$SDGR Leadership Updates

Live Leadership Updates

Schrödinger Appoints Geoffrey Porges as Chief Financial Officer

Schrödinger Announces Appointment of Arun Oberoi to Board of Directors

$SDGR Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Leerink Partners initiated coverage on Schrodinger with a new price target

KeyBanc Capital Markets initiated coverage on Schrodinger with a new price target

Piper Sandler resumed coverage on Schrodinger with a new price target

Recent Analyst Ratings for
$SDGR

$SDGR
Press Releases

$SDGR
Financials

$SDGR
Insider Trading

$SDGR
SEC Filings

$SDGR
Large Ownership Changes

$SDGR
Market Insights

$SDGR
Leadership Updates

$SDGR
Analyst Ratings